Santen Pharmaceutical Co. Ltd.

SNPHY | OTC

Price Alert Chart Builder DCF Calculator

$11.23

+$0.45 (+4.17%)

At close: Oct 30, 2026, 3:15 PM ET

$11.23

$0.00 (0.00%)

After-hours: Oct 30, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

+4.17%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

62.1

-0.9 pts

Fundamentals Strong

Market Sentiment Neutral

Moat Narrow

Sector Rank #115/1028 (Top 11%)

Full Analysis

Key Statistics

Market Data

Market Cap $3.64B

1D Range

11.23 11.23

52W Range

9.62 13.90

Valuation (TTM)

PE 14.57

PB 1.97

EV/EBITDA 8.02

Valuation (NTM)

Forward PE 13.27

Forward PEG 0.65

Price Target $0.00

Cash Flow

FCF Yield 6.1%

SBC Adj. FCF Yield 6.1%

SBC Impact N/A

Margins

Gross Margin 56.1%

Operating Margin 15.7%

FCF Margin 12.0%

Growth (CAGR)

Revenue 3Y | 5Y 0.7% | 2.6%

Dil EPS 3Y | 5Y 23.2% | 35.0%

FCF 3Y | 5Y 19.2% | 3.9%

Returns

ROA 9.3%

ROE 13.4%

ROIC 10.9%

Financial Health

Net Cash

¥47.25B ($290.74M)

Current Ratio 2.82

Interest Coverage 23.07

Dividends

Div Yield 2.05%

Payout Ratio 0.2%

FCF Payout Ratio 35.0%

All Key Statistics

Loading financial charts...

Profile

Santen Pharmaceutical Co., Ltd. is a global enterprise dedicated to the research, development, manufacturing, and distribution of pharmaceuticals and medical devices, with operations spanning Japan an...

Sector Healthcare

Industry Drug Manufacturers - General

Employees 3,968

IPO Date Aug 31, 2011

Website www.santen.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.